Although the mechanism for TRPC6 activation remains unclear, abnormal changes in angiotensin II and reactive oxygen species (ROS) in the DKD setting can stimulate overexpression of TRPC6 in podocytes. Here, TRPC6 is linked to diabetic kidney disease.